Malaria

::::::

 

Malaria

First-ever malaria vaccine recommendation now published in a position paper and in the WHO guidelines for malaria
4 March 2022 Departmental news
WHO today published an updated position paper on the RTS,S/AS01 (RTS,S) malaria vaccine that includes the October 2021 recommendation calling for the wider use of the vaccine among children living in areas of moderate-to-high P. falciparum malaria transmission. The paper complements the recent addition of the recommendation to the WHO Guidelines for malaria.
“The first malaria vaccine is a major step forward for malaria control, child health and health equity. If implemented broadly, the vaccine could save tens of thousands of lives each year,” said Dr Kate O’Brien, director of the Department of Immunization, Vaccines and Biologicals. “This guidance is essential to countries as they consider whether and how to adopt the vaccine as an additional tool to reduce child illness and deaths from malaria,” she added.
…Coming soon: additional malaria vaccine tools for countries
This newly published guidance will be followed in the coming months by additional tools and information to guide countries that have decided to adopt the malaria vaccine – including a new malaria vaccine introduction guide and an operational manual for sub-national tailoring of malaria control tools…

Malaria vaccine: WHO position paper – March 2022
4 March 2022
Overview
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in children living in areas of moderate to high malaria transmission. It also incorporates findings from the evaluation of the WHO-coordinated Malaria Vaccine Implementation Programme (MVIP), recommended by SAGE and MPAG in 2015, and from additional studies since 2015.
This paper does not include findings on vaccine efficacy in infants first vaccinated at 6–12 weeks of age. Because of the lower vaccine efficacy observed in this age category, WHO did not recommend pilot implementation or RTS,S/AS01 vaccine introduction for these young infants. Recommendations2 on the use of RTS,S/AS01 vaccine were discussed by SAGE and MPAG during a joint session in October 2021; evidence presented at the meeting can be accessed at https://terrance.who.int/mediacentre/data/ sage/SAGE_eYB_Oct2021.pdf

Workshop on WHO policy guidance on malaria elimination and the implementation of the intensification plans for reducing malaria burden in the Greater Mekong subregion
Virtual meeting, 22–23 November 2021
1 March 2022
Overview
The Workshop was convened virtually from 22 to 23 November 2021. Organized by the Mekong Malaria Elimination (MME) programme, it brought together participants from the 6 GMS countries – Cambodia, China, the Lao People’s Democratic Republic, Myanmar, Thailand and Viet Nam – and the Global Malaria Programme, as well as technical experts and partners to help GMS countries with the task of eliminating malaria and prepare them for the process of verification and certification of malaria